Yongjia Jin

The toxicity of cell therapy: Mechanism, manifestations, and challenges

Y. Dong, Yarong Liu, Jin Zhang, 2020, Journal of applied toxicology : JAT.

Combination of pembrolizumab plus temozolomide therapy in unresectable and advanced melanoma: a multicenter retrospective analysis in China

Yong Chen, Zhiguo Luo, Wei-li Sun, 2021, Annals of translational medicine.

Application of Carbonyl Iron Powder as a Novel Mediator for Arterial Embolization Hyperthermia—Feasibility Investigation

Jintian Tang, Xiaowen Wang, Xufei Wang, 2009 .

Surgical resection margin for T3–T4 primary acral melanoma: a multicenter retrospective cohort study

Wangjun Yan, Chunmeng Wang, Yong Chen, 2023, Archives of Dermatological Research.

CDCA2 promotes melanoma progression by inhibiting ubiquitin-mediated degradation of Aurora kinase A.

Wanlin Liu, Yong Chen, Wei-li Sun, 2023, European journal of cancer.

miR-5195-3p Suppresses Cell Proliferation and Induces Apoptosis by Directly Targeting NEDD9 in Osteosarcoma.

G. Shi, Xuan Yang, Yongjia Jin, 2019, Cancer biotherapy & radiopharmaceuticals.

The combination of apatinib and antigen-specific DC-induced T cells exert antitumor effects by potently improving the immune microenvironment of osteosarcoma

Yongjia Jin, Tuoping Hu, Yan Dong, 2024, Heliyon.